A. J. Lees

3.0k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

A. J. Lees is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, A. J. Lees has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Neurology. Recurrent topics in A. J. Lees's work include Neurological disorders and treatments (16 papers), Parkinson's Disease Mechanisms and Treatments (14 papers) and Genetic Neurodegenerative Diseases (7 papers). A. J. Lees is often cited by papers focused on Neurological disorders and treatments (16 papers), Parkinson's Disease Mechanisms and Treatments (14 papers) and Genetic Neurodegenerative Diseases (7 papers). A. J. Lees collaborates with scholars based in United Kingdom, United States and Australia. A. J. Lees's co-authors include Peter Kempster, Janice L. Holton, S. S. O'Sullivan, E.R. Maher, C. D. Marsden, Andrew M. Jenner, Peter Jenner, N. J. Cairns, Barry Halliwell and S. E. Daniel and has published in prestigious journals such as Brain, Neurology and Journal of Neurochemistry.

In The Last Decade

A. J. Lees

31 papers receiving 2.1k citations

Hit Papers

Oxidative DNA Damage in the Parkinsonian Brain: An Appare... 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. J. Lees United Kingdom 15 1.5k 582 463 359 312 31 2.1k
Olof Sydow Sweden 26 1.1k 0.8× 896 1.5× 535 1.2× 223 0.6× 229 0.7× 49 2.0k
M. C. de Rijk Netherlands 11 1.7k 1.2× 568 1.0× 309 0.7× 367 1.0× 300 1.0× 11 2.3k
Tommaso Schirinzi Italy 29 1.4k 1.0× 813 1.4× 708 1.5× 357 1.0× 328 1.1× 138 2.6k
Mitsutoshi Yamamoto Japan 28 1.4k 0.9× 705 1.2× 445 1.0× 327 0.9× 267 0.9× 69 2.1k
Yvette Bordelon United States 26 1.6k 1.0× 834 1.4× 499 1.1× 404 1.1× 368 1.2× 70 2.5k
Icíar Avilés-Olmos United Kingdom 19 1.8k 1.2× 898 1.5× 488 1.1× 463 1.3× 346 1.1× 39 2.7k
Shu‐Leong Ho Hong Kong 31 1.1k 0.7× 518 0.9× 873 1.9× 619 1.7× 271 0.9× 52 2.6k
Hortensia Alonso‐Navarro Spain 29 1.4k 0.9× 552 0.9× 510 1.1× 295 0.8× 184 0.6× 148 2.6k
Iddo Magen Israel 24 840 0.6× 617 1.1× 598 1.3× 402 1.1× 215 0.7× 38 2.0k
Marina Svetel Serbia 28 1.8k 1.2× 933 1.6× 491 1.1× 303 0.8× 475 1.5× 149 2.9k

Countries citing papers authored by A. J. Lees

Since Specialization
Citations

This map shows the geographic impact of A. J. Lees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Lees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Lees more than expected).

Fields of papers citing papers by A. J. Lees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Lees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Lees. The network helps show where A. J. Lees may publish in the future.

Co-authorship network of co-authors of A. J. Lees

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Lees. A scholar is included among the top collaborators of A. J. Lees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Lees. A. J. Lees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selikhova, Marianna, et al.. (2016). Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Clinical Neurology and Neurosurgery. 147. 71–77. 9 indexed citations
2.
Noyce, Alastair J., JP Bestwick, Laura Silveira‐Moriyama, et al.. (2013). PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results. Journal of Neurology Neurosurgery & Psychiatry. 85(1). 31–37. 75 indexed citations
3.
Gontu, Vamsi, et al.. (2010). Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. Journal of Neurology Neurosurgery & Psychiatry. 81(11). 1223–1228. 81 indexed citations
4.
Kempster, Peter, S. S. O'Sullivan, Janice L. Holton, Tamás Révész, & A. J. Lees. (2010). Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain. 133(6). 1755–1762. 298 indexed citations
5.
Gilman, Sid, Gregor K. Wenning, David J. Brooks, et al.. (2008). Second consensus statement on the diagnosis of multiple system atrophy. UCL Discovery (University College London). 6 indexed citations
6.
O'Sullivan, S. S., Luke A. Massey, David R. Williams, et al.. (2008). Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. 131(5). 1362–1372. 288 indexed citations
7.
Williams, David R. & A. J. Lees. (2008). How do patients with parkinsonism present? A clinicopathological study. Internal Medicine Journal. 39(1). 7–12. 32 indexed citations
8.
Lees, A. J., et al.. (2006). The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. Journal of Neurology Neurosurgery & Psychiatry. 78(6). 571–575. 11 indexed citations
9.
Lees, A. J., G.W. Barton, & Lucy Kershaw. (2003). The Use Of Kohonen Neural Network Analysis To Qualitatively Characterize Technique In Soccer Kicking. Journal of Sports Sciences. 7 indexed citations
10.
Gibson, Gary E., Ann E. Kingsbury, Hui Xu, et al.. (2003). Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson’s disease. Neurochemistry International. 43(2). 129–135. 91 indexed citations
11.
Utton, Michelle A., James W. Connell, Ayodeji A. Asuni, et al.. (2002). The mechanism of slow axonal transport of the microtubule-associated protein tau and the transport rates of different isoforms and mutants. UCL Discovery (University College London). 1 indexed citations
12.
Morris, Huw R., Anette Schrag, David J. Burn, et al.. (2001). Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neuroscience Letters. 312(2). 118–120. 21 indexed citations
13.
Münchau, Alexander, Philip J. Allen, N. Quinn, et al.. (2001). Polymyography Combined with Time-Locked Video Recording (Video EMG) for Presurgical Assessment of Patients with Cervical Dystonia. European Neurology. 45(4). 222–228. 6 indexed citations
14.
Jenner, Andrew M., S. E. Daniel, A. J. Lees, et al.. (1997). Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra. Journal of Neurochemistry. 69(3). 1196–1203. 667 indexed citations breakdown →
15.
Rascol, O., et al.. (1996). Ropinirole in the Treatment of Levodopa-Induced Motor Fluctuations in Patients with Parkinson's Disease. Clinical Neuropharmacology. 19(3). 234–245. 90 indexed citations
16.
Turjanski, N., Zvezdan Pirtošek, J. A. Quirk, et al.. (1996). Botulinum Toxin in the Treatment of Writer's Cramp. Clinical Neuropharmacology. 19(4). 314–320. 26 indexed citations
17.
Robertson, Mary M., Vivienne Schnieden, & A. J. Lees. (1990). Management of Gilles de la Tourette Syndrome Using Sulpiride. Clinical Neuropharmacology. 13(3). 229–235. 70 indexed citations
18.
Gibb, W R, A. J. Lees, & John W Scadding. (1985). Persistent rheumatic chorea. Neurology. 35(1). 101–101. 10 indexed citations
19.
Jayne, David, A. J. Lees, & G M Stern. (1984). Remission in spasmodic torticollis.. Journal of Neurology Neurosurgery & Psychiatry. 47(11). 1236–1237. 33 indexed citations
20.
Lander, Cecilie M., A. J. Lees, & G M Stern. (1979). Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.. PubMed. 16. 197–203. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026